Analytüberwachung durch Dritte

Details

Veröffentlichungs-Nr.

EP4721660

Anmeldetag

28. Januar 2022

Veröffentlichung

8. April 2026

Rechtsraum

EP

IPC

A61B5/145, G16H15/00(RAISONI BARKHA et al.)

Abstract

Digital and graphical user interfaces for third party analyte monitoring applications are provided. For example, disclosed herein are various embodiments of methods, systems, and interfaces for connection interfaces, alarm notification settings interfaces, and logbook interfaces in a third party analyte monitoring application. In addition, various embodiments of interface enhancements are described, including enhanced visibility mode and interfaces for setting up a third party analyte monitoring application, among other embodiments.

Anmelder

Firma

Abbott Diabetes Care Inc.

Land

🇺🇸 USA